Shares in 4D Pharma closed down 30% on Tuesday but recovered some losses on Wednesday
PLC () on Wednesday said it was not aware of any reason for the recent fall in its share price.
The pharmaceutical company also confirmed that all clinical study timelines continue to progress as expected.
“ notes the recent fall in its share price and confirms that it is not aware of any company related matter which could be responsible for this price movement. The board also confirms that all clinical study timelines continue to progress as expected,” the company said in a statement.
Shares in closed down 30% on Tuesday but were 10% up at 98p in late morning trade on Wednesday.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of 4D pharma plc named herein, including the promotion by the Company of 4D pharma plc in any Content on the Site, the Company receives from said...
FOR OUR FULL DISCLAIMER CLICK HERE